Sandoz sees a win on US Combigan appeal
Executive Summary
Sandoz has gained a further advantage in its bid to introduce a generic of Allergan’s Combigan (brimonidine/timolol) 0.2%/0.5% eye drops in the US, following a favourable US Court of Appeals ruling.
You may also be interested in...
Apotex Moves First On Combigan As US Patent Expiry Looms
Apotex has moved first on Allergan’s Combigan, introducing a US authorized generic as the clock ticks on the originator’s IP. Sandoz is among ANDA sponsors seemingly waiting for patent protection to lapse.
CEO Kevin Ali Marks Organon’s Progress In First Post-Spin Year
A year after Organon spun out of Merck, the company has delivered on its financial guidance, generated double-digit biosimilars sales growth and executed six deals to grow in women’s health.
HBW US Market News: FTC Returns 'Free Trial' Losses, Old Spice Targets 'Meat Sweats,' More
FTC returns more than $5.4m to more than 100,000 consumers from "free trial" scam;" Hood College names Nutrition Science Program's founding director; Cremer introduces gummy-counting machine; Herbalife renovates LA headquarters; Arby's and Old Spice team up to fight "meat sweats."